Dr John Goodlad

  • Honorary Clinical Senior Lecturer (School of Cancer Sciences)

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2021
Number of items: 5.

2024

Bouttell, J. , Fraser, H. , Goodlad, J. R., Hopkins, D. , McKay, P., Oien, K. A. , Seligmann, B., Von Delft, S. and Hawkins, N. (2024) Adding a gene expression profile test to aid differential diagnosis and treatment in aggressive large B-cell lymphoma: an early exploratory economic evaluation. Applied Health Economics and Health Policy, 22(2), pp. 243-254. (doi: 10.1007/s40258-023-00845-1) (PMID:38017318)

2023

Bouttell, J. , Hawkins, N. , Masson, R. and Goodlad, J. (2023) OP79 Gene Expression Profiling In The Diagnosis Of Aggressive Large B Cell Lymphoma: An Early Exploratory Economic Evaluation. HTAi 2023 Annual Meeting, Adelaide, Australia, 24-28 June 2023. S21–S21. (doi: 10.1017/s0266462323000995)

Goodlad, J. R., Cerroni, L. and Swerdlow, S. H. (2023) Recent advances in cutaneous lymphoma—implications for current and future classifications. Virchows Archiv, 482(1), pp. 281-298. (doi: 10.1007/s00428-022-03421-5) (PMID:36278991) (PMCID:PMC9852132)

2021

Frontzek, F. et al. (2021) Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma. Nature Communications, 12, 5183. (doi: 10.1038/s41467-021-25405-w) (PMID:34465776) (PMCID:PMC8408158)

Wilson, M. R. , Gordon, W., Goodlad, J., Leach, M. and Bain, B. J. (2021) Erdheim‐Chester disease in bone marrow. American Journal of Hematology, 96(2), pp. 270-271. (doi: 10.1002/ajh.25948) (PMID:33398894)

This list was generated on Sat Oct 12 23:01:39 2024 BST.
Number of items: 5.

Articles

Bouttell, J. , Fraser, H. , Goodlad, J. R., Hopkins, D. , McKay, P., Oien, K. A. , Seligmann, B., Von Delft, S. and Hawkins, N. (2024) Adding a gene expression profile test to aid differential diagnosis and treatment in aggressive large B-cell lymphoma: an early exploratory economic evaluation. Applied Health Economics and Health Policy, 22(2), pp. 243-254. (doi: 10.1007/s40258-023-00845-1) (PMID:38017318)

Goodlad, J. R., Cerroni, L. and Swerdlow, S. H. (2023) Recent advances in cutaneous lymphoma—implications for current and future classifications. Virchows Archiv, 482(1), pp. 281-298. (doi: 10.1007/s00428-022-03421-5) (PMID:36278991) (PMCID:PMC9852132)

Frontzek, F. et al. (2021) Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma. Nature Communications, 12, 5183. (doi: 10.1038/s41467-021-25405-w) (PMID:34465776) (PMCID:PMC8408158)

Wilson, M. R. , Gordon, W., Goodlad, J., Leach, M. and Bain, B. J. (2021) Erdheim‐Chester disease in bone marrow. American Journal of Hematology, 96(2), pp. 270-271. (doi: 10.1002/ajh.25948) (PMID:33398894)

Conference or Workshop Item

Bouttell, J. , Hawkins, N. , Masson, R. and Goodlad, J. (2023) OP79 Gene Expression Profiling In The Diagnosis Of Aggressive Large B Cell Lymphoma: An Early Exploratory Economic Evaluation. HTAi 2023 Annual Meeting, Adelaide, Australia, 24-28 June 2023. S21–S21. (doi: 10.1017/s0266462323000995)

This list was generated on Sat Oct 12 23:01:39 2024 BST.